investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of Activity of Lonidamine

Jerry D Glickson

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Andrew Halestrap

University of Bristol

Bristol, United Kingdom

Jerry D Glickson

University of Pennsylvania

Philadelphia, United States

Related projects

Carl D Novina

(PQD1) Evolution of Vemurafenib Resistance in Circulating Melanoma Cells

Melanoma of skin

Pathology

William W Bachovchin

Using FAP to Selectively Target Epithelial Cancers

Melanoma of skin

Pathology

Ann Ager

Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity

Melanoma of skin

Pathology

Mel Greaves

Evolutionary biology of cancer

Melanoma of skin

Pathology

Investigator from MRC Biostatistics Unit (MRC)

Bias-adjusted inference in Biostatistics

Melanoma of skin All cancers but non-melanoma skin cancer

Myriam Hemberger

PARP1 is essential to maintain the epigenetic hallmarks of imprinting control regions

Melanoma of skin All cancers but non-melanoma skin cancer

Investigator from Medical Research Council

The role of OTULIN and Met1-linked ubiquitin in immune signaling and host defense in vivo

Melanoma of skin All cancers but non-melanoma skin cancer

Erika L Pearce

TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY

Melanoma of skin All cancers but non-melanoma skin cancer

Amanda G Paulovich

Advanced development of immuno-MRM technology to analyze archived cancer tissues

Melanoma of skin All cancers but non-melanoma skin cancer